OBO_ID (LABEL):	CHEBI_15365 (acetylsalicylic acid)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4896250	4/2016	S2586-PMC4896250	['among the ‘certain’ cases by who-umc causality assessment system, the most common agent was Acetylsalicylic Acid (13.5%), followed by Paracetamol (6.7%), Iopromide (5.6%).']	N/A	N/A	[('CHEBI_15365', 'acetylsalicylic acid', 92, 'acetylsalicylic acid'), ('CHEBI_46195', 'paracetamol', 134, 'paracetamol'), ('CHEBI_63578', 'iopromide', 154, 'iopromide')]
PMC5029029	9/2016	S69-PMC5029029	['cya Cyclosporine A, asa Acetyl Salicylic Acid, pred.']	N/A	N/A	[('CHEBI_4810', 'Epivoacorine', 4, 'cyclosporine A'), ('CHEBI_15365', 'acetylsalicylic acid', 24, 'acetyl salicylic acid')]
PMC5029029	9/2016	S73-PMC5029029	['cya Cyclosporine A, asa Acetyl Salicylic Acid, pred.']	N/A	N/A	[('CHEBI_4810', 'Epivoacorine', 4, 'cyclosporine A'), ('CHEBI_15365', 'acetylsalicylic acid', 24, 'acetyl salicylic acid')]
PMC5133238	12/2016	S18-PMC5133238	['oral Acetylsalicylic Acid (100 mg), subcutaneous Enoxaparin (4,000 iu; last dose 16 hours before cs), and Antenatal Vitamins had been administered since early Pregnancy.']	N/A	N/A	[('CHEBI_15365', 'acetylsalicylic acid', 5, 'acetylsalicylic acid'), ('CHEBI_4798', 'entacapone', 49, 'enoxaparin'), ('GO_0007567', 'parturition', 106, 'antenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 116, 'vitamins'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy')]
PMC5537884	7/2017	S36-PMC5537884	['the patient was treated with Acetylsalicylic Acid (75 mg/day) from the seventh Gestational week; Alpha-Methyldopa was used from the ninth Gestational week to control hypertension (maximum dosage of 1 g/day at term).']	N/A	N/A	[('CHEBI_15365', 'acetylsalicylic acid', 29, 'Acetylsalicylic acid'), ('GO_0007565', 'female pregnancy', 79, 'gestational'), ('CHEBI_82070', 'Dichlozoline', 97, 'Alpha-Methyldopa'), ('GO_0007565', 'female pregnancy', 138, 'gestational')]
PMC5537884	7/2017	S55-PMC5537884	['at the start of her Pregnancy, her treatment consisted of 125 mg/day of Cyclosporine A and 75 mg/day of Acetylsalicylic Acid; an ace inhibitor (ramipril) was discontinued at a positive Pregnancy test.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnancy'), ('CHEBI_4810', 'Epivoacorine', 72, 'cyclosporine A'), ('CHEBI_15365', 'acetylsalicylic acid', 104, 'acetylsalicylic acid'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
